Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GRI | GRI BIO INC | United States | $1.31M | 3,196,488 | 6.80% | 86.05% | ||
| SANA | SANA BIOTECHNOLOGY INC | United States | $2.30B | 220,447,557 | 47.20% | 52.80% | Net Buying | Net Buying |
| FWBI | FIRST WAVE BIOPHARMA INC | United States | $5.27M | 2,025,199 | 0.08% | 99.92% | Net Selling | Net Selling |
| MBIO | MUSTANG BIO INC | United States | $3.30M | 10,390,132 | 9.95% | 24.56% | ||
| PHGE | BIOMX INC | United States | $21.20M | 55,220,077 | 14.70% | 48.14% | Net Buying | |
| VINC | VINCERX PHARMA INC | United States | $18.78M | 21,413,389 | 45.80% | 53.71% | Net Buying | |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | United States | $3.03B | 123,896,914 | 62.55% | 10.70% | Net Selling | Net Selling |
| PMN | PROMIS NEUROSCIENCES INC | Canada | $37.16M | 18,961,116 | 17.66% | 24.49% | ||
| TELO | TELOMIR PHARMACEUTICALS INC | United States | $183.58M | 29,609,814 | 0.00% | 16.90% | Net Buying | Net Buying |
| CTCX | CARMELL CORP | United States | $42.34M | 19,245,248 | 11.98% | 59.11% | Net Buying | |
| ANEB | ANEBULO PHARMACEUTICALS INC | United States | $76.50M | 25,933,217 | 24.84% | 75.16% | ||
| ABVC | ABVC BIOPHARMA INC | United States | $11.41M | 10,560,421 | 0.52% | 99.48% | ||
| APTO | APTOSE BIOSCIENCES INC | Canada | $18.86M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| ERNA | ETERNA THERAPEUTICS INC | United States | $10.04M | 5,410,331 | 0.91% | 99.09% | Net Selling | |
| AEON | AEON BIOPHARMA INC | United States | $64.24M | 37,788,858 | 22.93% | 61.40% | Net Selling | |
| EFTR | EFFECTOR THERAPEUTICS INC | United States | $8.11M | 3,687,309 | 18.84% | 81.16% | Net Selling | |
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | United States | $406.82M | 10,493,108 | 5.76% | 94.24% | Net Buying | Net Buying |
| SER | SERINA THERAPEUTICS INC | United States | $20.76M | 2,500,664 | 12.90% | 87.10% | ||
| KA | KINETA INC | United States | $6.47M | 10,962,460 | 3.76% | 96.24% | Net Buying | Net Buying |
| JAGX | JAGUAR HEALTH INC | United States | $87.84M | 276,216,260 | 0.45% | 3.48% | ||
| NVAX | NOVAVAX INC | United States | $689.97M | 139,953,143 | 55.43% | 19.60% | Net Selling | Net Selling |
| PSTV | PLUS THERAPEUTICS INC | United States | $7.70M | 4,276,082 | 0.60% | 99.40% | Net Buying | |
| ARMP | ARMATA PHARMACEUTICALS INC | United States | $90.01M | 36,148,539 | 1.55% | 98.45% | ||
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.87M | 439,926,480 | 0.79% | 0.00% | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | United States | $79.97M | 119,359,230 | 54.24% | 11.13% | Net Buying | Net Selling |
| ZVSA | ZYVERSA THERAPEUTICS INC | United States | $4.14M | 759,486 | 4.63% | 95.37% | ||
| DRMA | DERMATA THERAPEUTICS INC | United States | $2.24M | 6,660,840 | 4.01% | 95.99% | ||
| ENGN | ENGENE HOLDINGS INC | Canada | $675.95M | 43,581,331 | 32.55% | 27.91% | Net Buying | Net Buying |
| ACXP | ACURX PHARMACEUTICALS INC | United States | $34.19M | 15,757,102 | 6.93% | 15.26% | Net Buying | |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | Canada | N/A | 27,282,165 | 0.00% | 0.00% | ||
| MAIA | MAIA BIOTECHNOLOGY INC | United States | $65.61M | 20,002,826 | 4.02% | 22.12% | Net Buying | Net Buying |
| IBIO | IBIO INC | United States | $6.93M | 3,484,266 | 0.72% | 99.28% | Net Selling | |
| GRTX | GALERA THERAPEUTICS INC | United States | $10.12M | 54,392,170 | 23.78% | 62.30% | Net Selling | Net Selling |
| CVM | CEL SCI CORP | United States | $81.67M | 50,104,231 | 12.96% | 43.81% | Net Buying | Net Buying |
| YS | YS BIOPHARMA CO LTD | China | $68.68M | 93,058,197 | 10.08% | 0.00% | ||
| HUMA | HUMACYTE INC | United States | $525.16M | 119,083,728 | 14.97% | 36.38% | Net Selling | |
| ELTX | ELICIO THERAPEUTICS INC | United States | $91.91M | 10,235,469 | 3.25% | 92.54% | Net Buying | |
| RANI | RANI THERAPEUTICS HOLDINGS INC | United States | $358.62M | 50,157,292 | 5.88% | 51.66% | Net Buying | |
| HCWB | HCW BIOLOGICS INC | United States | $50.31M | 37,823,394 | 2.82% | 47.89% | Net Buying | Net Buying |
| KPRX | KIORA PHARMACEUTICALS INC | United States | $13.47M | 26,256,197 | 1.15% | 47.24% | ||
| ICCC | IMMUCELL CORP | United States | $38.99M | 7,750,864 | 13.45% | 24.31% | Net Buying | |
| ALZN | ALZAMEND NEURO INC | United States | $4.99M | 6,866,846 | 0.97% | 99.03% | Net Buying | Net Buying |
| CING | CINGULATE INC | United States | $4.84M | 5,010,471 | 0.05% | 99.95% | Net Buying | Net Buying |
| QLGN | QUALIGEN THERAPEUTICS INC | United States | $1.90M | 6,307,371 | 0.87% | 99.13% | ||
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $111.91M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| UNCY | UNICYCIVE THERAPEUTICS INC | United States | $38.93M | 34,756,436 | 37.49% | 18.00% | ||
| ACHV | ACHIEVE LIFE SCIENCES INC | United States | $162.18M | 34,251,911 | 7.96% | 27.78% | Net Buying | Net Selling |
| ENSC | ENSYSCE BIOSCIENCES INC | United States | $4.11M | 7,329,172 | 0.72% | 57.99% | ||
| BCLI | BRAINSTORM CELL THERAPEUTICS INC | United States | $25.97M | 68,341,857 | 5.79% | 54.09% | Net Buying | Net Buying |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $110.33M | 32,260,510 | 26.67% | 12.70% | ||
| NRXP | NRX PHARMACEUTICALS INC | United States | $20.10M | 9,569,978 | 6.23% | 93.77% | Net Buying | |
| SKYE | SKYE BIOSCIENCE INC | United States | N/A | 28,062,907 | 0.00% | 100.00% | Net Buying | Net Buying |
| CHRO | CHROMOCELL THERAPEUTICS CORP | United States | $10.40M | 5,877,835 | 0.00% | 47.70% | Net Buying | Net Buying |
| VCNX | VACCINEX INC | United States | $7.45M | 1,231,602 | 18.31% | 81.69% | Net Buying | Net Buying |
| PTN | PALATIN TECHNOLOGIES INC | United States | $34.05M | 16,136,640 | 8.26% | 91.74% | Net Selling | Net Selling |
| NRSN | NEUROSENSE THERAPEUTICS LTD | Israel | $20.45M | 15,379,042 | 0.92% | 0.00% | ||
| ALLR | ALLARITY THERAPEUTICS INC | United States | $308.95k | 308,945 | 4.41% | 95.59% | ||
| SLS | SELLAS LIFE SCIENCES GROUP INC | United States | $74.84M | 56,267,670 | 6.21% | 13.47% | Net Selling | |
| CNSP | CNS PHARMACEUTICALS INC | United States | $2.35M | 10,634,932 | 2.97% | 5.30% | Net Buying | |
| AKTX | AKARI THERAPEUTICS PLC | United States | $21.55M | 15,847,391,523 | 0.00% | 59.09% | ||
| IVA | INVENTIVA SA | France | $171.98M | 52,115,807 | 9.33% | 0.00% | ||
| BCTX | BRIACELL THERAPEUTICS CORP | Canada | $36.12M | 15,981,726 | 15.42% | 12.34% | ||
| VTVT | VTV THERAPEUTICS INC | United States | $71.13M | 3,010,206 | 0.11% | 99.89% | Net Buying | Net Buying |
| KTRA | KINTARA THERAPEUTICS INC | United States | $5.89M | 39,037,899 | 0.62% | 27.90% | ||
| ANVS | ANNOVIS BIO INC | United States | $57.04M | 11,011,299 | 10.94% | 26.91% | Net Buying | |
| OKYO | OKYO PHARMA LTD | United Kingdom | $38.84M | 25,553,274 | 0.15% | 99.85% | Net Buying | |
| CDT | CONDUIT PHARMACEUTICALS INC | United States | $221.49M | 73,829,536 | 1.86% | 73.61% | ||
| RNXT | RENOVORX INC | United States | $20.58M | 16,865,975 | 1.96% | 20.25% | Net Buying | |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $89.34M | 27,918,560 | 18.78% | 38.25% | ||
| ATNF | 180 LIFE SCIENCES CORP | United States | $1.71M | 852,772 | 7.45% | 92.55% | Net Buying | |
| GALT | GALECTIN THERAPEUTICS INC | United States | $206.76M | 61,903,672 | 8.36% | 91.64% | Net Buying | Net Selling |
| ONCO | ONCONETIX INC | United States | $2.75M | 22,327,701 | 10.85% | 21.37% | ||
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD | Israel | $2.03M | 1,453,970,784 | 0.03% | 0.05% | ||
| INKT | MINK THERAPEUTICS INC | United States | $34.01M | 34,699,056 | 2.85% | 72.02% | Net Buying | Net Buying |
| ICU | SEASTAR MEDICAL HOLDING CORP | United States | $33.86M | 75,419,458 | 1.23% | 19.86% | Net Buying | |
| NLSP | NLS PHARMACEUTICS LTD | Switzerland | $4.92M | 35,671,780 | 16.35% | 0.00% | ||
| OCEA | OCEAN BIOMEDICAL INC | United States | $50.20M | 34,149,046 | 13.42% | 75.32% | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $7.00M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| TVGN | TEVOGEN BIO HOLDINGS INC | United States | $159.68M | 164,614,418 | 1.46% | 96.20% | Net Selling | |
| NKGN | NKGEN BIOTECH INC | United States | $32.61M | 22,805,643 | 15.84% | 84.16% | Net Buying | |
| PBM | PSYENCE BIOMEDICAL LTD | Canada | $15.53M | 13,390,659 | 3.69% | 66.53% | Net Selling |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.